Business
Joint development agreement signed with Royal DSM
Joint development agreement signed with Royal DSM.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 1258U OptiBiotix Health PLC 05 April 2016 \n\n5 April 2016\n \nOptiBiotix Health plc\n(\"OptiBiotix\" or \"the Company\")\n \nJoint Development Agreement signed with Royal DSM \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that it has entered into a joint development agreement with Royal DSM. The agreement allows for collaboration between both parties to develop new products using OptiBiotix's OptiBiotic® technology platform.\n \nRoyal DSM is a global science based company active in health, nutrition and materials with approximately 25,000 employees and annual net sales in the region of €10 billion. Its Nutritional Products business is one of the world's leading suppliers of vitamins, carotenoids, nutritional lipids and other ingredients in the food, pharmaceutical and personal care industries. \n \nIf successful, the agreement allows both parties to agree commercial terms such that OptiBiotix grants an exclusive licence to DSM in the DSM field, and an option to license in other fields, in return for royalty payments on sales of future products.\n \nStephen O'Hara, CEO of OptiBiotix, commented: \"We are pleased to announce the signing of a joint development agreement with DSM, one of the world's leading suppliers of nutritional ingredients. We believe that OptiBiotix's strong science base together with DSM's innovation focus and global reach will help both companies bring better science and better health to people around the world.\"\n \n \nFor further information, please contact:\n \n\n\n\n\nOptiBiotix Health plc\n\n\nwww.optibiotix.com\n\n\n\n\nStephen O'Hara, Chief Executive\n\n\nContact via Walbrook below\n\n\n\n\n\n\n\n\n\n\n\n\nCairn Financial Advisers LLP\n\n\nTel: 020 7148 7900\n\n\n\n\nLiam Murray \n\n\n\n\n\n\n\nAvi Robinson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nHybridan LLP (Joint Broker)\n\n\nTel: 020 3764 2341\n\n\n\n\nClaire Louise Noyce\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeterhouse Corporate Finance Ltd (Joint Broker)\n\n\nTel: 020 7469 0936\n\n\n\n\nLucy Williams\n\n\n\n\n\n\n\nDuncan ...